We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




New Contrast-Enhanced Ultrasound Application to Enhance Diagnostic Confidence for Cancer Patients

By MedImaging International staff writers
Posted on 13 Sep 2023
Print article
Image: The super resolution contrast-enhanced ultrasound application is available on the EPIQ Elite ultrasound system (Photo courtesy of Philips)
Image: The super resolution contrast-enhanced ultrasound application is available on the EPIQ Elite ultrasound system (Photo courtesy of Philips)

In order to diagnose and treat cancer, understanding the blood flow dynamics in and out of a suspicious lesion is crucial for healthcare providers. The traditional method of assessing this involves injecting an iodinated contrast media intravenously, but this isn't suitable for everyone. As an alternative, contrast-enhanced ultrasound (CEUS) is gaining traction. CEUS employs micro-bubble contrast media made from an inert gas, which leaves the body when the patient exhales.

Philips (Amsterdam, Noord-Holland) has taken a step forward by incorporating super resolution microvascular imaging (MVI) CEUS in its EPIQ Elite ultrasound system. This new addition enhances spatial resolution by up to 200% compared to older systems. Just like other CEUS methods, super resolution MVI does not subject patients to ionizing radiation, and is generally both more budget-friendly and widely available. Furthermore, compared to traditional iodinated contrast media, the micro-bubble contrast media used in CEUS has a much lower rate of adverse reactions. The MVI technology by Philips enables doctors to closely monitor the contrast media's entry into a lesion as well as its pattern over time, enhancing diagnostic certainty for lesions that are hard to classify.

As a top-of-the-line ultrasound system, the EPIQ Elite fuses cutting-edge transducer technology with superior performance to bolster clinical assurance and offer customized patient care. The system is equipped with a multitude of diagnostic applications and specialized tools designed to cater to the unique demands of various medical fields. The EPIQ Elite excels in delivering both exceptional clinical outcomes and the efficient workflow needed to cope with the high pressures of modern medical practice.

Related Links:
Philips 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Enterprise Imaging & Reporting Solution
Syngo Carbon
New
FMT Radiographic Suite
AdvantagePlus ML1
New
Fetal Monitor
Avante Compact II

Print article

Channels

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.